Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma.
DiPaola RS, Chenven ES, Shih WJ, Lin Y, Amenta P, Goodin S, Shumate A, Capanna T, Cardiella M, Cummings KB, Aisner J, Todd MB.
DiPaola RS, et al. Among authors: lin y.
Cancer. 2001 Oct 15;92(8):2065-71. doi: 10.1002/1097-0142(20011015)92:8<2065::aid-cncr1546>3.0.co;2-k.
Cancer. 2001.
PMID: 11596021
Clinical Trial.